Gene therapy targeting monocyte chemoattractant protein-1 for vascular disease.

Shiro Kitamoto, Kensuke Egashira

Research output: Contribution to journalReview article

21 Citations (Scopus)

Abstract

Monocyte chemoattractant protein-1 (MCP-1) has been shown to play an essential role in the pathogenesis of arteriosclerosis and other vascular diseases, such as restenosis after arterial injury, by recruiting monocytes into the arterial wall. We devised a new strategy for anti-MCP-1 gene therapy against arteriosclerosis by transfecting an amino-terminal deletion mutant (7ND), which lacks the amino-terminal amino acids 2 to 8 of the human MCP-1 gene, into a remote organ (skeletal muscles). Intramuscular transduction with the mutant MCP-1 gene suppressed inflammatory and proliferative changes and arteriosclerosis formation induced by the chronic inhibition of nitric oxide synthesis in rats. 7ND gene transfection also inhibited the initiation, progression, and destabilization of atherosclerosis in Apolipoprotein E-knockout mice. Moreover, the strategy reduced restenosis after balloon injury in rabbits, rats, and monkeys, or neointimal formation after stent implantation in monkeys. This new strategy may be a useful and feasible gene therapy against atherosclerosis and restenosis after angioplasty.

Original languageEnglish
Pages (from-to)261-265
Number of pages5
JournalJournal of atherosclerosis and thrombosis
Volume9
Issue number6
DOIs
Publication statusPublished - 2002

Fingerprint

Gene therapy
Gene Targeting
Arteriosclerosis
Chemokine CCL2
Vascular Diseases
Genetic Therapy
Genes
Haplorhini
Rats
Atherosclerosis
Stents
Balloons
Wounds and Injuries
Apolipoproteins E
Mutant Proteins
Angioplasty
Knockout Mice
Transfection
Muscle
Monocytes

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Cardiology and Cardiovascular Medicine
  • Biochemistry, medical

Cite this

Gene therapy targeting monocyte chemoattractant protein-1 for vascular disease. / Kitamoto, Shiro; Egashira, Kensuke.

In: Journal of atherosclerosis and thrombosis, Vol. 9, No. 6, 2002, p. 261-265.

Research output: Contribution to journalReview article

@article{f3659e31bc98459193c247dad68406a5,
title = "Gene therapy targeting monocyte chemoattractant protein-1 for vascular disease.",
abstract = "Monocyte chemoattractant protein-1 (MCP-1) has been shown to play an essential role in the pathogenesis of arteriosclerosis and other vascular diseases, such as restenosis after arterial injury, by recruiting monocytes into the arterial wall. We devised a new strategy for anti-MCP-1 gene therapy against arteriosclerosis by transfecting an amino-terminal deletion mutant (7ND), which lacks the amino-terminal amino acids 2 to 8 of the human MCP-1 gene, into a remote organ (skeletal muscles). Intramuscular transduction with the mutant MCP-1 gene suppressed inflammatory and proliferative changes and arteriosclerosis formation induced by the chronic inhibition of nitric oxide synthesis in rats. 7ND gene transfection also inhibited the initiation, progression, and destabilization of atherosclerosis in Apolipoprotein E-knockout mice. Moreover, the strategy reduced restenosis after balloon injury in rabbits, rats, and monkeys, or neointimal formation after stent implantation in monkeys. This new strategy may be a useful and feasible gene therapy against atherosclerosis and restenosis after angioplasty.",
author = "Shiro Kitamoto and Kensuke Egashira",
year = "2002",
doi = "10.5551/jat.9.261",
language = "English",
volume = "9",
pages = "261--265",
journal = "Journal of Atherosclerosis and Thrombosis",
issn = "1340-3478",
publisher = "Japan Atherosclerosis Society",
number = "6",

}

TY - JOUR

T1 - Gene therapy targeting monocyte chemoattractant protein-1 for vascular disease.

AU - Kitamoto, Shiro

AU - Egashira, Kensuke

PY - 2002

Y1 - 2002

N2 - Monocyte chemoattractant protein-1 (MCP-1) has been shown to play an essential role in the pathogenesis of arteriosclerosis and other vascular diseases, such as restenosis after arterial injury, by recruiting monocytes into the arterial wall. We devised a new strategy for anti-MCP-1 gene therapy against arteriosclerosis by transfecting an amino-terminal deletion mutant (7ND), which lacks the amino-terminal amino acids 2 to 8 of the human MCP-1 gene, into a remote organ (skeletal muscles). Intramuscular transduction with the mutant MCP-1 gene suppressed inflammatory and proliferative changes and arteriosclerosis formation induced by the chronic inhibition of nitric oxide synthesis in rats. 7ND gene transfection also inhibited the initiation, progression, and destabilization of atherosclerosis in Apolipoprotein E-knockout mice. Moreover, the strategy reduced restenosis after balloon injury in rabbits, rats, and monkeys, or neointimal formation after stent implantation in monkeys. This new strategy may be a useful and feasible gene therapy against atherosclerosis and restenosis after angioplasty.

AB - Monocyte chemoattractant protein-1 (MCP-1) has been shown to play an essential role in the pathogenesis of arteriosclerosis and other vascular diseases, such as restenosis after arterial injury, by recruiting monocytes into the arterial wall. We devised a new strategy for anti-MCP-1 gene therapy against arteriosclerosis by transfecting an amino-terminal deletion mutant (7ND), which lacks the amino-terminal amino acids 2 to 8 of the human MCP-1 gene, into a remote organ (skeletal muscles). Intramuscular transduction with the mutant MCP-1 gene suppressed inflammatory and proliferative changes and arteriosclerosis formation induced by the chronic inhibition of nitric oxide synthesis in rats. 7ND gene transfection also inhibited the initiation, progression, and destabilization of atherosclerosis in Apolipoprotein E-knockout mice. Moreover, the strategy reduced restenosis after balloon injury in rabbits, rats, and monkeys, or neointimal formation after stent implantation in monkeys. This new strategy may be a useful and feasible gene therapy against atherosclerosis and restenosis after angioplasty.

UR - http://www.scopus.com/inward/record.url?scp=0141526098&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141526098&partnerID=8YFLogxK

U2 - 10.5551/jat.9.261

DO - 10.5551/jat.9.261

M3 - Review article

C2 - 12560586

AN - SCOPUS:0141526098

VL - 9

SP - 261

EP - 265

JO - Journal of Atherosclerosis and Thrombosis

JF - Journal of Atherosclerosis and Thrombosis

SN - 1340-3478

IS - 6

ER -